Anaesthetists use specific drugs peri-operatively to try to decrease the incidence and severity of postoperative pain and of postoperative nausea and vomiting. These drugs are usually administered pre-operatively with the premedication, or intra-operatively when the patient is still anaesthetised. The aim of this approach is to prevent the occurrence of intolerable pain or to avoid any nausea or vomiting symptoms which may be clearly unpleasant for the patient and which interfere with the patient's well-being, recovery and satisfaction. However, since most of these drugs are given prophylactically, and since not all patients will actually be suffering from intolerable pain or severe nausea and vomiting symptoms postoperatively, many patients will receive these drugs unnecessarily. Thus, for the individual patient, the risk of suffering from drug-related adverse reactions without profiting from any benefit may be relevant. Perhaps a ‘wait-and-see' approach should be considered; especially non-steroidal anti-inflammatory drugs or dexamethasone should not be given pre-operatively to all patients but should be provided exclusively to those in whom alternative analgesics (for instance, paracetamol combined with a weak opioid) or alternative anti-emetics (for instance, a setron or droperidol) have failed or are associated with unacceptable adverse effects. There is no evidence that prophylactic administration of an analgesic or an anti-emetic is more efficacious than the therapeutic administration. An interesting alternative to achieve satisfactory posttonsillectomy analgesia may be with local anaesthesia swabs that are applied onto the wound.

1.
Van den Akker EH, Hoes AW, Burton MJ, Schilder AG: Large international differences in (adeno)tonsillectomy rates. Clin Otolaryngol Allied Sci 2004;29:161-164.
2.
Fedeli U, Marchesan M, Avossa F, et al: Variability of adenoidectomy/tonsillectomy rates among children of the Veneto Region, Italy. BMC Health Serv Res 2009;9:25.
3.
Gan TJ, Meyer TA, Apfel CC, et al: Society for Ambulatory Anesthesia guidelines for the management of postoperative nausea and vomiting. Anesth Analg 2007;105:1615-1628.
4.
Kranke P, Eberhart LH: Possibilities and limitations in the pharmacological management of postoperative nausea and vomiting. Eur J Anaesthesiol 2011;28:758-765.
5.
Anderson BJ: Paracetamol (acetaminophen): mechanisms of action. Paediatr Anaesth 2008;18:915-921.
6.
Elia N, Lysakowski C, Tramèr MR: Does multimodal analgesia with acetaminophen, nonsteroidal antiinflammatory drugs, or selective cyclooxygenase-2 inhibitors and patient-controlled analgesia morphine offer advantages over morphine alone? Meta-analyses of randomized trials. Anesthesiology 2005;103:1296-1304.
7.
Howard CR, Howard FM, Weitzman ML: Acetaminophen analgesia in neonatal circumcision: the effect on pain. Pediatrics 1994;93:641-646.
8.
Rusy LM, Houck CS, Sullivan LJ, et al: A double-blind evaluation of ketorolac tromethamine versus acetaminophen in pediatric tonsillectomy: analgesia and bleeding. Anesth Analg 1995;80:226-229.
9.
Mather SJ, Peutrell JM: Postoperative morphine requirements, nausea and vomiting following anaesthesia for tonsillectomy. Comparison of intravenous morphine and non-opioid analgesic techniques. Paediatr Anaesth 1995;5:185-188.
10.
Silvanto M, Munsterhjelm E, Savolainen S, et al: Effect of 3 g of intravenous paracetamol on post-operative analgesia, platelet function and liver enzymes in patients undergoing tonsillectomy under local anaesthesia. Acta Anaesthesiol Scand 2007;51:1147-1154.
11.
Watkins PB, Kaplowitz N, Slattery JT, et al: Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA 2006;296:87-93.
12.
Anderson BJ, Woolard GA, Holford NH: Pharmacokinetics of rectal paracetamol after major surgery in children. Paediatr Anaesth 1995;5:237-242.
13.
Korpela R, Korvenoja P, Meretoja OA: Morphine-sparing effect of acetaminophen in pediatric day-case surgery. Anesthesiology 1999;91:442-447.
14.
Fransen M, Anderson C, Douglas J, et al: Safety and efficacy of routine postoperative ibuprofen for pain and disability related to ectopic bone formation after hip replacement surgery (HIPAID): randomised controlled trial. BMJ 2006;333:519.
15.
Krishna S, Hughes LF, Lin SY: Postoperative hemorrhage with nonsteroidal anti-inflammatory drug use after tonsillectomy: a meta-analysis. Arch Otolaryngol Head Neck Surg 2003;129:1086-1089.
16.
Marret E, Flahault A, Samama CM, Bonnet F: Effects of postoperative, nonsteroidal, antiinflammatory drugs on bleeding risk after tonsillectomy: meta-analysis of randomized, controlled trials. Anesthesiology 2003;98:1497-1502.
17.
Møiniche S, Rømsing J, Dahl JB, Tramèr MR: Nonsteroidal antiinflammatory drugs and the risk of operative site bleeding after tonsillectomy: a quantitative systematic review. Anesth Analg 2003;96:68-77.
18.
Cardwell M, Siviter G, Smith A: Non-steroidal anti-inflammatory drugs and perioperative bleeding in paediatric tonsillectomy. Cochrane Database Syst Rev 2005;2:CD003591.
19.
Rømsing J, Ostergaard D, Drozdziewicz D, Schultz P, Ravn G: Diclofenac or acetaminophen for analgesia in paediatric tonsillectomy outpatients. Acta Anaesthesiol Scand 2000;44:291-295.
20.
Henzi I, Walder B, Tramèr MR: Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg 2000;90:186-194.
21.
Apfel CC, Korttila K, Abdalla M, et al: A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med 2004;350:2441-2451.
22.
Steward DL, Welge JA, Myer CM: Do steroids reduce morbidity of tonsillectomy? Meta-analysis of randomized trials. Laryngoscope 2001;111:1712-1718.
23.
Afman CE, Welge JA, Steward DL: Steroids for post-tonsillectomy pain reduction: meta-analysis of randomized controlled trials. Otolaryngol Head Neck Surg 2006;134:181-186.
24.
April MM, Callan ND, Nowak DM, Hausdorff MA: The effect of intravenous dexamethasone in pediatric adenotonsillectomy. Arch Otolaryngol Head Neck Surg 1996;122:117-120.
25.
Tom LW, Templeton JJ, Thompson ME, Marsh RR: Dexamethasone in adenotonsillectomy. Int J Pediatr Otorhinolaryngol 1996;37:115-120.
26.
Pappas AL, Sukhani R, Hotaling AJ, et al: The effect of preoperative dexamethasone on the immediate and delayed postoperative morbidity in children undergoing adenotonsillectomy. Anesth Analg 1998;87:57-61.
27.
Hanasono MM, Lalakea ML, Mikulec AA, Shepard KG, Wellis V, Messner AH: Perioperative steroids in tonsillectomy using electrocautery and sharp dissection techniques. Arch Otolaryngol Head Neck Surg 2004;130:917-921.
28.
Czarnetzki C, Elia N, Lysakowski C, et al: Dexamethasone and risk of nausea and vomiting and postoperative bleeding after tonsillectomy in children: a randomized trial. JAMA 2008;300:2621-2630.
29.
Durmus M, Karaaslan E, Ozturk E, et al: The effects of single-dose dexamethasone on wound healing in rats. Anesth Analg 2003;97:1377-1380.
30.
Carpani de Kaski M, Rentsch R, Levi S, Hodgson HJ: Corticosteroids reduce regenerative repair of epithelium in experimental gastric ulcers. Gut 1995;37:613-616.
31.
Steward DL, Grisel J, Meinzen-Derr J: Steroids for improving recovery following tonsillectomy in children. Cochrane Database Syst Rev 2011;8:CD003997.
32.
Diakos EA, Gallos ID, El-Shunnar S, Clarke M, Kazi R, Mehanna H: Dexamethasone reduces pain, vomiting and overall complications following tonsillectomy in adults: a systematic review and meta-analysis of randomised controlled trials. Clin Otolaryngol 2011;36:531-542.
33.
Ahmed KA, Dreher ME, King RF, et al: Dexamethasone and postoperative bleeding risk after adenotonsillectomy in children. Laryngoscope 2011;121:1060-1061.
34.
Gallagher TQ, Hill C, Ojha S, et al: Perioperative dexamethasone administration and risk of bleeding following tonsillectomy in children: a randomized controlled trial. JAMA 2012;308:1221-1226.
35.
Kim MK, Lee JW, Kim MG, Ha SY, Lee JS, Yeo SG: Analysis of prognostic factors for postoperative bleeding after tonsillectomy. Eur Arch Otorhinolaryngol 2012;269:977-981.
36.
Plante J, Turgeon AF, Zarychanski R, et al: Effect of systemic steroids on post-tonsillectomy bleeding and reinterventions: systematic review and meta-analysis of randomised controlled trials. BMJ 2012;345:e5389.
37.
Dayer P, Desmeules J, Leemann T, Striberni R: Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufI). Biochem Biophys Res Commun 1988;152:411-416.
38.
Gasche Y, Daali Y, Fathi M, et al: Codeine intoxication associated with ultrarapid CYP2D6 metabolism. N Engl J Med 2004;351:2827-2831.
39.
Ciszkowski C, Madadi P, Phillips MS, Lauwers AE, Koren G: Codeine, ultrarapid-metabolism genotype, and postoperative death. N Engl J Med 2009;361:827-828.
40.
Kelly LE, Rieder M, van den Anker J, et al: More codeine fatalities after tonsillectomy in North American children. Pediatrics 2012;129:e1343-e1347.
41.
McLellan RA, Oscarson M, Seidegård J, Evans DA, Ingelman-Sundberg M: Frequent occurrence of CYP2D6 gene duplication in Saudi Arabians. Pharmacogenetics 1997;7:187-191.
42.
Hollis LJ, Burton MJ, Millar JM: Perioperative local anaesthesia for reducing pain following tonsillectomy. Cochrane Database Syst Rev 2000;2:CD001874.
43.
Grainger J, Saravanappa N: Local anaesthetic for post-tonsillectomy pain: a systematic review and meta-analysis. Clin Otolaryngol 2008;33:411-419.
44.
Bean-Lijewski JD: Glossopharyngeal nerve block for pain relief after pediatric tonsillectomy: retrospective analysis and two cases of life-threatening upper airway obstruction from an interrupted trial. Anesth Analg 1997;84:1232-1238.
45.
Cyna AM, Bell KR, Flood LM: Cervical osteomyelitis following tonsillectomy. Anaesthesia 1997;52:1084-1087.
46.
Alsarraf R, Sie KC: Brain stem stroke associated with bupivacaine injection for adenotonsillectomy. Otolaryngol Head Neck Surg 2000;122:572-573.
47.
Fradis M, Goldsher M, David JB, Podoshin L: Life-threatening deep cervical abscess after infiltration of the tonsillar bed for tonsillectomy. Ear Nose Throat J 1998;77:418-421.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.